天域生物(603717.SH):公司當前的市淨率高於同行業平均水
格隆匯12月10日丨天域生物(603717.SH)公佈,公司股票自2024年11月18日以來,累計升幅達57.24%,其中近3個交易日連續升停,累計升幅較大,可能存在非理性炒作風險和股價短期升幅較大後續下跌的風險,截至2024年12月10日,公司股票收盤價格為9.23元/股,市淨率為4.13倍。根據中證指數有限公司發佈的證監會行業數據顯示,截至2024年12月10日,公司所處的“A03畜牧業”市淨率為2.74倍,公司當前的市淨率高於同行業平均水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.